<?xml version="1.0" encoding="UTF-8"?><REUTERS CGISPLIT="TRAINING-SET" LEWISSPLIT="TRAIN" NEWID="1449" OLDID="17867" TOPICS="YES">
<DATE> 4-MAR-1987 09:56:01.20</DATE>
<TOPICS><D>earn</D></TOPICS>
<PLACES><D>usa</D></PLACES>
<PEOPLE/>
<ORGS/>
<EXCHANGES/>
<COMPANIES/>
<UNKNOWN> 
   F
   f0253 reute
d f BC-MOLECULAR-GENETICS-IN   03-04 0085</UNKNOWN>
<TEXT> 
<TITLE>MOLECULAR GENETICS INC &lt;MOGN&gt; 4TH QTR LOSS</TITLE>
<DATELINE>    MINNETONKA, Minn., March 4 -
    </DATELINE><BODY>Oper shr loss 22 cts vs loss 13 cts
    Oper net loss 1,712,916 vs loss 769,539
    Revs 2,292,972 vs 2,157,895
    Avg shrs 7,961,602 vs 6,200,293
    Year
    Oper shr loss 53 cts vs loss 45 cts
    Oper net loss 3,562,151 vs 2,543,366
    Revs 9,117,311 vs 8,251,136
    Avg shrs 7,169,871 vs 6,186,51
    NOTE: Current year net both periods excludes charge 430,649
dlrs from cumulative effect of accounting change for patents.
    1986 net both periods includes charge of about 458,000 dlrs
from severance obligations.
    1986 year net includes charge 156,000 dlrs from writeoff of
seed commitments.
 Reuter
 </BODY></TEXT>
</REUTERS>